Five proposals for activities aiming to promote Nordic clinical research cooperation related to international activities have been granted support from the Nordic Trial Alliance at NordForsk.
The activities are intended to move Nordic collaboration within certain areas of clinical studies forward, strengthen knowledge transfer and have a concrete outcome that will enhance Nordic clinical research cooperation, states NordForsk.
Read more: The potential of joint Nordic life science efforts
Up to NOK 400 000
The call for proposals opened in October, and ended 19 November 2021. Example of activities foreseen were strategic workshops, networking activities, knowledge transfer, coordination of national initiatives, including trials etc. All proposals are supported with up to NOK 400 000.
Read more: Different COVID-19 strategies in the Nordic countries
Proposals to be funded
The LD-VenEx clinical trial for Acute Myeloid Leukaemia – Bjørn Tore Gjertsen, Oslo University Hospital, Norway
NorEpiNet – Kaja Selmer, Oslo University Hospital, Norway
The Nordic SBRT study group: infrastructure and clinical research – Karin Lindberg, Karolinska University Hospital, Sweden
The Nordic Precision Cancer Medicine Trial Network – Kjetil Taskén, Oslo University Hospital, Norway
Establishment of Network for Nordic Pediatric Clinical trial Units – René Mathiasen, Rigshospitalet, Denmark/NordicPedMed
About the Nordic Trial Alliance
The Nordic Trial Alliance (NTA) is a project with the aim to facilitate clinical research co-operation in the Nordic region and focus on multi-centre clinical trials. NTA is based on established national networks for clinical research and will lay the foundation for increased collaboration between national and Nordic stakeholders.
NTA is funded by the Nordic Council of Ministers and NordForsk.
Illustration: iStock
